Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe-Reference-Cited by-同舟云学术

Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe

Published:2017-08-29 Issue:1 Volume:60 Page:201-210
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Miller Anne-Marie¹,Balasa Mircea²,Blennow Kaj³,Gardiner Mary⁴,Rutkowska Aleksandra¹,Scheltens Philip⁵,Teunissen Charlotte E.⁶,Visser Pieter Jelle⁵⁷,Winblad Bengt⁸,Waldemar Gunhild⁹,Lawlor Brian²¹⁰

Affiliation:

1. Medical Gerontology, School of Medicine, Trinity College, Dublin, Ireland

2. Global Brain Health Institute, Trinity College Institute of Neuroscience, Trinity College Dublin, Ireland

3. Clinical Neurochemistry Lab, Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden

4. Immunology Laboratory, St. James’s Hospital, Dublin, Ireland

5. Department of Neurology/Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands

6. Department of Clinical Chemistry, Neurochemistry Lab and Biobank, Neurocampus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands

7. Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, Maastricht University Medical Centre, School for Mental Health and Neuroscience, Maastricht, The Netherlands

8. Department NVS, Karolinska Institute, Centre for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden

9. Department of Neurology, Danish Dementia Research Centre, Neuroscience Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

10. Mercer’s Institute for Successful Ageing, St. James’s Hospital, Dublin, Ireland

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference39 articles.

1. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease;McKhann;Neurology,1984

2. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia;Varma;J Neurol Neurosurg Psychiatry,1999

3. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer’s Disease Centers, 2005-2010;Beach;J Neuropathol Exp Neurol,2012

4. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease;Salloway;New Engl J Med,2014

5. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia;Jack;Neurology,2002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCL10/IgG1 Axis in Multiple Sclerosis as a Potential Predictive Biomarker of Disease Activity;Neurology Neuroimmunology & Neuroinflammation;2024-03

2. Rule-Based Identification of Individuals with Mild Cognitive Impairment or Alzheimer’s Disease Using Clinical Notes from the United States Veterans Affairs Healthcare System;Neurology and Therapy;2023-09-25

3. Understanding Barriers Along the Patient Journey in Alzheimer’s Disease Using Social Media Data;Neurology and Therapy;2023-04-15

4. From protein biomarkers to proteomics in dementia with Lewy Bodies;Ageing Research Reviews;2023-01

5. Association of Cerebrovascular and Alzheimer Disease Biomarkers With Cholinergic White Matter Degeneration in Cognitively Unimpaired Individuals;Neurology;2022-08-02